Sign in

You're signed outSign in or to get full access.

Jay Leveton

President at StagwellStagwell
Executive

About Jay Leveton

Jay Leveton is President of Stagwell Inc. (STGW), joining the executive team following the August 2021 Business Combination; his employment agreement is dated Sept. 12, 2021, with a current base salary of $800,000 and annual bonus target up to 80% of base salary . His incentives are tied primarily to cumulative Adjusted EBITDA over three-year LTIP cycles; STGW exceeded the 2021 LTIP target (100% vest), while the 2022 LTIP missed the minimum threshold and was partially vested at 82% via committee discretion (execution risk) . Say-on-pay support was >99% in 2024, signaling shareholder acceptance of the pay design . Age and education are not disclosed in the 2025 proxy .

Past Roles

OrganizationRoleYearsStrategic Impact
Stagwell Inc.President2021–present Helped set incentive targets with CEO/CFO in annual planning; alignment to Adjusted EBITDA and KPI-based objectives
Stagwell Media (pre-merger)Executive (former Stagwell Media executive)Pre–Aug 2021 Part of leadership added at Business Combination; supports integration and growth agenda

External Roles

No external directorships or outside roles for Mr. Leveton are disclosed in the 2025 proxy .

Fixed Compensation

Metric202220232024
Base Salary ($)$725,000 $781,250 $800,000
Target Bonus % of SalaryUp to 80% Up to 80% Up to 80%
Actual Bonus Paid ($)$0 $0 $0
All Other Compensation ($)$16,359 $26,507 $24,742

2024 “All Other Compensation” for Jay consists of health benefits of $24,742; no airfare/perquisites disclosed .

Performance Compensation

Annual Incentive Awards (AIA) — one-year service-based equity in lieu of cash bonus

Award YearGrant DateAward TypeShares/UnitsVestingNotes
2022Feb 23, 2023Restricted Shares90,843 Feb 23, 2024 Committee replaced cash bonuses with equity
2023Mar 8, 2024RSUs92,578 Mar 8, 2025 Committee replaced cash bonuses with equity
2024Mar 7, 2025RSUs88,535 Mar 8, 2025 Committee replaced cash bonuses with equity

The HRCC did not pay cash annual bonuses in 2022–2024, citing Adjusted EBITDA performance; it substituted one-year equity and selective cash retention (not applicable to Mr. Leveton) .

Long-Term Incentive Plan (LTIP) — performance-based equity tied to cumulative Adjusted EBITDA

LTIP CycleAward TypeTarget SharesPerformance MetricPerformance PeriodVesting/Status
2021 LTIPPerformance RS86,000 Cumulative Adjusted EBITDA target: $1.1B 2021–2023 100% vested Mar 31, 2024 (target exceeded)
2022 LTIPPerformance RS144,861 Cumulative Adjusted EBITDA target: $1.425B 2022–2024 Missed minimum; committee vested 82% at target → 118,786 shares vested Mar 31, 2025; remainder forfeited
2023 LTIPPerformance RS131,722 Cumulative Adjusted EBITDA target: $1.425B 2023–2025 Vests Mar 1, 2026, subject to performance & service
2024 LTIPPerformance RSUs183,688 (Target) Cumulative Adjusted EBITDA target: $1.325B 2024–2026 Vests Mar 8, 2027; threshold 80% to max 120% payout slope

2024 LTIP payout scale: <80% target → 0% earned; 80–100% → 80–100% earned; 100–120% → 100–120% earned, straight-line interpolation .

Equity Ownership & Alignment

Ownership MeasureValue
Beneficial ownership (Apr 18, 2025)2,602,724 shares; <1% of outstanding (“*”)
Unvested RSUs at 12/31/2492,578 units (vested Mar 8, 2025)
Unearned performance awards at 12/31/24460,271 units (sum of 2022, 2023, 2024 LTIP targets)
Pledged/Hedged sharesNone; hedging prohibited; pledging limited to 40% with approval; currently no officer/director pledging/hedging

Equity award timing policy: annual grants generally follow Q4 and FY earnings release; no timing around MNPI .

Employment Terms

TermKey Economics
Employment Agreement DateSept 12, 2021
Base Salary$725,000 initially; $800,000 effective Apr 1, 2023
Target BonusUp to 80% of base salary
Signing Bonus$325,000 (paid)
Severance (no CiC)6 months salary continuation upon termination without cause
Restrictive Covenants2-year client non-solicit; employee/consultant non-solicit; services restrictions, with exceptions
ClawbackExecutive compensation clawback for restatements (post Oct 1, 2023 awards); 2022 revisions did not trigger recovery

Potential Payments Upon Termination (as of Dec 31, 2024)

ScenarioCash Severance ($)Healthcare ($)Additional Vested Equity ($)Total ($)
Termination not within CiC period400,000 2,245,247 2,645,247
Termination within CiC period (double-trigger for LTIP)400,000 3,637,746 4,037,746
Death or disability3,637,746 3,637,746

LTIP grants accelerate to 100% of target on termination without cause/for good reason within one year after a Change in Control or on death/disability; outside CiC, pro-rata vesting based on service months applies, subject to performance .

Investment Implications

  • Compensation structure vs performance: Heavy equity mix and multi-year Adjusted EBITDA LTIPs align pay with long-term performance; however, 2022 LTIP required discretionary vesting at 82% despite missing minimum target, introducing pay-for-performance looseness and execution risk .
  • Vesting calendar and potential selling pressure: Significant 2025 vesting events occurred (92,578 RSUs on Mar 8, 2025 and 118,786 2022 LTIP shares on Mar 31, 2025), which can create near-term supply; subsequent performance LTIPs (2023/2024 cycles) are service- and results-constrained to 2026/2027 .
  • Alignment and risk controls: Meaningful beneficial ownership (2.6M shares) and no pledging/hedging indicate alignment; hedging prohibited and pledging capped (none currently), with a clawback policy in place for financial restatements .
  • Change-in-control economics: Modest cash severance (0.5x salary) but substantial equity acceleration under double-trigger in a CiC scenario ($3.64M additional vesting value as of year-end 2024), implying retention value and potential deal-related incentive alignment .
  • Shareholder sentiment: >99% say-on-pay approval in 2024 suggests investors accept the program design despite discretion used in 2022 LTIP .